Cited by 410Alzheimer's disease research and treatmentsDementia and Cognitive Impairment ResearchNeuroinflammation and Neurodegeneration Mechanisms

The DOI matches its Crossref record; 59 of the 59 references it cites were found in a registry or an index.

Nicotinamide Restores Cognition in Alzheimer's Disease Transgenic Mice via a Mechanism Involving Sirtuin Inhibition and Selective Reduction of Thr231-Phosphotau

Open access

Green, Kim N., Steffan, Joan S., Martinez-Coria, Hilda, Sun, Xuemin, Schreiber, Steven S., Thompson, Leslie Michels, LaFerla, Frank M.·2008·The Journal of Neuroscience

DOI 10.1523/jneurosci.3203-08.2008PMC PMC2617713

Open this paper in CoChat — free account Open PDF

Abstract

Memory loss is the signature feature of Alzheimer's disease, and therapies that prevent or delay its onset are urgently needed. Effective preventive strategies likely offer the greatest and most widespread benefits. Histone deacetylase (HDAC) inhibitors increase histone acetylation and enhance memory and synaptic plasticity. We evaluated the efficacy of nicotinamide, a competitive inhibitor of the sirtuins or class III NAD + -dependent HDACs in 3xTg-AD mice, and found that it restored cognitive deficits associated with pathology. Nicotinamide selectively reduces a specific phospho-species of tau (Thr231) that is associated with microtubule depolymerization, in a manner similar to inhibition of SirT1. Nicotinamide also dramatically increased acetylated α-tubulin, a primary substrate of SirT2, and MAP2c, both of which are linked to increased microtubule stability. Reduced phosphoThr231-tau was related to a reduction of monoubiquitin-conjugated tau, suggesting that this posttranslationally modified form of tau may be rapidly degraded. Overexpression of a Thr231-phospho-mimic tau in vitro increased clearance and decreased accumulation of tau compared with wild-type tau. These preclinical findings suggest that oral nicotinamide may represent a safe treatment for AD and other tauopathies, and that phosphorylation of tau at Thr231 may regulate tau stability.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1523/jneurosci.3203-08.2008

Cites

59 of 59 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

1 retracted

RETRACTED ARTICLE: A specific amyloid-β protein assembly in the brain impairs memory
Lesné, S., Koh, M. T., Kotilinek, L., Kayed, R., Glabe, C. G., Yang, A., Gallagher, M., & Ashe, K. H. (2006) · Nature · doi:10.1038/nature04533 · Cited by 2,769
Retracted
Amyloid oligomers exacerbate tau pathology in a mouse model of tauopathy
Selenica, M.-L. B., Brownlow, M., Jimenez, J. P., Lee, D. C., Pena, G., Dickey, C. A., Gordon, M. N., & Morgan, D. (2013) · Neurodegenerative Diseases · doi:10.1159/000337230 · Cited by 10,359
Resveratrol improves health and survival of mice on a high-calorie diet
Baur, J. A., Pearson, K. J., Price, N. L., Jamieson, H. A., Lerin, C., Kalra, A., Prabhu, V. V., Allard, J. S., Lopez-Lluch, G., Lewis, K., et al. (2006) · Nature · doi:10.1038/nature05354 · Cited by 4,290 · cited 1×
“The sirtuin family of deacetylases is implicated in cellular pathways that influence longevity in yeast, C. elegans, Drosophila, and mammals (Tissenbaum and Guarente, 2001; Anderson et al., 2003; Howitz et al., 2003; Wood et al., 2004; Baur et al., 2006).”
Background
Triple-Transgenic Model of Alzheimer’s Disease with Plaques and Tangles
Oddo, S., Caccamo, A., Shepherd, J. D., Murphy, M. P., Golde, T. E., Kayed, R., Metherate, R., Mattson, M. P., Akbari, Y., & LaFerla, F. M. (2003) · Neuron · doi:10.1016/s0896-6273(03)00434-3 · Cited by 4,126 · cited 6×
“By 8 months, somatodendritic accumulation of phospho- and non-phosphotau also occurs in the hippocampus and amygdala, but not the cortex (Oddo et al., 2003).”
BackgroundMethodInfluentialSelf-citation
Small molecule activators of sirtuins extend Saccharomyces cerevisiae lifespan
Howitz, K. T., Bitterman, K. J., Cohen, H. Y., Lamming, D. W., Lavu, S., Wood, J. G., Zipkin, R. E., Chung, P., Kisielewski, A., Zhang, L.-L., et al. (2003) · Nature · doi:10.1038/nature01960 · Cited by 3,796
A new one-trial test for neurobiological studies of memory in rats. 1: behavioral data
Ennaceur, A., & Delacour, J. (1988) · Behavioural Brain Research · doi:10.1016/0166-4328(88)90157-x · Cited by 3,223 · cited 1×
“Kim N. Green,1 Joan S. Steffan,2 Hilda Martinez-Coria,1 Xuemin Sun,3 Steven S. Schreiber,3,5 Leslie Michels Thompson,1,2,4 and Frank M. LaFerla1”
Background
Histone Acetyltransferases
Dent, S., Denu, J. M., & Allis, C. D. (2001) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.70.1.81 · Cited by 1,906 · cited 2×
“Acetylation of histones and nonhistone transcription factors plays an important role in regulating chromatin condensation and gene transcription (Roth et al., 2001).”
Background
Reducing Endogenous Tau Ameliorates Amyloid ß-Induced Deficits in an Alzheimer's Disease Mouse Model
Roberson, E. D., Scearce-Levie, K., Palop, J. J., Yan, F., Cheng, I. H., Wu, T., Gerstein, H., Yu, G.-Q., & Mucke, L. (2007) · Science · doi:10.1126/science.1141736 · Cited by 1,892
Sirtuin activators mimic caloric restriction and delay ageing in metazoans
Wood, J. G., Rogina, B., Lavu, S., Howitz, K., Helfand, S. L., Tatar, M., & Sinclair, D. (2004) · Nature · doi:10.1038/nature02789 · Cited by 1,868 · cited 1×
“The sirtuin family of deacetylases is implicated in cellular pathways that influence longevity in yeast, C. elegans, Drosophila, and mammals (Tissenbaum and Guarente, 2001; Anderson et al., 2003; Howitz et al., 2003; Wood et al., 2004; Baur et al., 2006).”
Background
Increased dosage of a sir-2 gene extends lifespan in Caenorhabditis elegans
Tissenbaum, H. A., & Guarente, L. (2001) · Nature · doi:10.1038/35065638 · Cited by 1,603 · cited 1×
“The sirtuin family of deacetylases is implicated in cellular pathways that influence longevity in yeast, C. elegans, Drosophila, and mammals (Tissenbaum and Guarente, 2001; Anderson et al., 2003; Howitz et al., 2003; Wood et al., 2004; Baur et al., 2006).”
Background

Show all 59 references

Research works printed but not linked: 1

10.1016/j.neuron.2005.01.040 · DOI · Paper page

Sorted by citations

Items 301–400 of 410

Relative efficacy of nicotinamide treatment of a mouse model of infantile Niemann-Pick C1 disease
Marshall, C. A., Borbon, I. A., & Erickson, R. P. (2016) · Journal of Applied Genetics · doi:10.1007/s13353-016-0367-0 · Cited by 7
“Importantly, nicotinamide was found to restore cognition in a mouse model of Alzheimers disease (Green et al. 2008).”
Background
Neuroprotection in Alzheimer’s Disease
Jain, K. K. (2011) · Humana Press eBooks · doi:10.1007/978-1-61779-049-2_8 · Cited by 7
Nicotinamide: a novel treatment for age-related macular degeneration?
Westenskow, P. D. (2017) · Stem Cell Investigation · doi:10.21037/sci.2017.10.01 · Cited by 7
“While they detected few differences between healthy and disease groups, they did make an interesting discovery: nicotinamide, which accelerates iPS-RPE differentiation and has been shown to prevent neurodegeneration in other systems (10,11), can modulate a set of genes and proteins that may contribute to AMD in iPS-RP…”
Background
Clinical Trials and Drug Development
Mahipal, A. (2014) · Cancer Control · doi:10.1177/107327481402100301 · Cited by 8
Precision Enzyme: Targeted Drug Discovery in Neurodegenerative Disorders
Paul, S., Tiwari, P. K., & Dubey, S. (2025) · Protein and Peptide Letters · doi:10.2174/0109298665391103250825102319 · Cited by 8
Advancement of disease-modifying therapy of Alzheimer’s disease: from the perspective of new revised criteria for diagnosis and staging of Alzheimer’s disease
Wu, J., Geng, C., Liu, L., & Tang, Y. (2025) · Medicine Plus · doi:10.1016/j.medp.2025.100112 · Cited by 8
Neuro-Nanocarriers: Redefining Treatment Pathways for Brain Disorders
Chauhan, A., Mori, D., Soniwala, M. M., Prajapati, B. G., & Shah, S. R. (2024) · BioNanoScience · doi:10.1007/s12668-024-01730-4 · Cited by 6
Enlargement of early endosomes and traffic jam in basal forebrain cholinergic neurons in Alzheimer's disease
Fahimi, A., Noroozi, M., & Salehi, A. (2021) · Handbook of clinical neurology · doi:10.1016/b978-0-12-819975-6.00011-x · Cited by 6
Lycopene Pretreatment Ameliorates Acute Ethanol Induced NAD+ Depletion in Human Astroglial Cells
Guest, J., Guillemin, G., Heng, B., & Grant, R. (2015) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2015/741612 · Cited by 6
Neurocognitive Function and Quality of Life Outcomes in the ONTRAC Study for Skin Cancer Chemoprevention by Nicotinamide
Martin, A. J., Dhillon, H. M., Vardy, J. L., Dalziell, R. A., Choy, B., Fernández‐Peñas, P., Dixon, A., Renton, C., George, G. S., Chinniah, N., et al. (2019) · Geriatrics · doi:10.3390/geriatrics4010031 · Cited by 6
“In mice, exposure to nicotinamide has been associated with improved short term memory [6], reduced cognitive decline in an Alzheimer’s model [6], and improved recovery from cortical contusion injury [7].”
Transcriptional Expression of Histone Acetyltransferases and Deacetylases During the Recovery of Acute Exercise in Mouse Hippocampus
Qian, P., Wang, S., Zhang, T., & Wu, J. (2024) · Journal of Molecular Neuroscience · doi:10.1007/s12031-024-02215-5 · Cited by 5
“In contrast, loss of HDAC5 impairs memory function (Agis-Balboa et al. 2013), and SIRT1-3 is essential for normal cognitive and synaptic function (Green et al. 2008; Kim et al. 2011; Michan et al. 2010).”
Nicotinamide derivatives protect the blood-brain barrier against oxidative stress
Zandona, A., Szecskó, A., Žunec, S., Jovanović, I. N., Bušić, V., Gašo-Sokač, D., Deli, M. A., Katalinić, M., & Veszelka, S. (2025) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2025.118018 · Cited by 7
Introduction to This Issue: The Seven Ages of Man ... (or Woman)
Marshall, E. J., Guerrini, I., & Thomson, A. D. (2009) · Alcohol and Alcoholism · doi:10.1093/alcalc/agn119 · Cited by 5
Synthesis and Antimicrobial Activity of Newly Synthesized Nicotinamides
Marković, B. A., Marinković, А., Antić‐Stanković, J., Mijatović, S., Cvijetić, I., Simić, M. R., & Arandjelović, I. (2024) · Pharmaceutics · doi:10.3390/pharmaceutics16081084 · Cited by 5
“…the onset of diabetes mellitus has still remained uncertain [26,27], this compound is considered progressively promising in the prevention of ischemic reperfusion in nerve and vascular cells [28], neurological dysfunctions [29–32], and development of distinct psychological disorders [33].”
Nutrition, Histone Epigenetic Marks, and Disease
Zempleni, J., Liu, D., & Xue, J. (2013) · Epigenetics and human health · doi:10.1007/978-3-642-36827-1_9 · Cited by 5
“Nicotinamide is a competitive inhibitor of the class III sirtuins, and it may restore some of the cognitive deficits in Alzheimer’s disease (Green et al. 2008).”
Background
Sirtuin Modulation as Novel Neuroprotective Strategy for Alzheimer’s Disease
Polito, L., Biella, G., & Albani, D. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-803690-7.00008-9 · Cited by 5
Dietary and Metabolic Compounds Affecting Covalent Histone Modifications
Milagro, F. I., & Martínez, J. A. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-805388-1.00020-1 · Cited by 4
Neuroprotection in Alzheimer Disease
Jain, K. K. (2019) · Springer protocols handbooks/Springer protocols · doi:10.1007/978-1-4939-9465-6_8 · Cited by 5
Tau and neurodegenerative disorders
Motoi, Y., Sahara, N., Kambe, T., & Hattori, N. (2010) · BioMolecular Concepts · doi:10.1515/bmc.2010.017 · Cited by 5
Target-guided Synthesis: Medicinal Chemistry Strategy to Allow Target Enzymes Themselves to Synthesize their Own Inhibitors
Itoh, Y., Miyata, N., & Suzuki, T. (2014) · Journal of Synthetic Organic Chemistry Japan · doi:10.5059/yukigoseikyokaishi.72.702 · Cited by 5
Metabolomics study to reveal cognitive improvement with treatment of Scrophularia buergeriana
Yoon, D., Oh, S. M., Na, H. S., Choi, B., Kim, K.-W., Lee, Y., Lee, D., & Lee, D. (2024) · Scientific Reports · doi:10.1038/s41598-024-66371-9 · Cited by 4
“Microtubules, which are responsible for transmitting information in brain cells, are destabilized by the phosphorylation of the Tau protein 20 .”
Background
Inhibition of Sirt2 Decreases ApoE Secretion in Astrocytes and Microglial Cells
Chen, Y., Zhou, C., Abdelhamid, M., Jung, C., & Michikawa, M. (2023) · The Journal of Biochemistry · doi:10.1093/jb/mvad054 · Cited by 4
Effect of iron deficiency on the expression of insulin-like growth factor-II and its receptor in neuronal and glial cells
González, E., Contreras, I., & Estrada, J. A. (2014) · Neurología (English Edition) · doi:10.1016/j.nrleng.2013.10.017 · Cited by 4
“There is also a link between vitamin B and increased levels of BDNF in the CNS.(24,25) Antioxidants like vitamins E and C may promote the protective effects of BDNF and ciliary neurotrophic factor in nervous tissue.”
Background
The Role of Epigenetic Mechanisms in Autoimmune, Neurodegenerative, Cardiovascular, and Imprinting Disorders
Nepali, K., Liou, J., Sharma, R., Sharma, S., Thakur, A., Singh, A., & Singh, J. (2022) · Mini-Reviews in Medicinal Chemistry · doi:10.2174/1389557522666220217103441 · Cited by 4
Epigenetic treatment of neurodegenerative disorders
Martínez-Iglesias, O. A., & Cacabelos, R. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-816422-8.00013-1 · Cited by 4
Calorie Restriction Mimetics: Progress and Potential
Roth, G. S., & Ingram, D. K. (2015) · Healthy ageing and longevity · doi:10.1007/978-3-319-14830-4_10 · Cited by 5
Nutrition and Dementia
Coppedè, F., Bosco, P., Fuso, A., & Troen, A. M. (2012) · Current Gerontology and Geriatrics Research · doi:10.1155/2012/926082 · Cited by 5
“Niacin status is not well studied in relation to dementia risk, either alone or in relation to methyl-group metabolism although there are experimental animal data showing benefits of supplementation [16].”
Background
Aging and the Brain
Prahlad, V., & Chikka, M. R. (2018) · Wiley eBooks · doi:10.1002/9781118772034.ch3 · Cited by 4
Nanoengineering and nanotechnology for diagnosis and treatment of CNS and neurological diseases
Kumar, P., Dwivedi, A., Plaimas, K., Sagar, K., & Chauhan, L. (2023) · Elsevier eBooks · doi:10.1016/b978-0-323-91182-5.00006-1 · Cited by 3
A novel cocrystal of indole-3-propionic acid and nicotinamide: Structure design, preparation, characterization and preliminary physiochemical properties evaluation
Guo, J., Xu, L., You, W., Ji, Y., & Chen, D. (2024) · Journal of Molecular Structure · doi:10.1016/j.molstruc.2024.140610 · Cited by 3
Calorie Restriction Mimetics From Functional Foods
Sun, W. Y., & Wang, Y. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-805376-8.00022-8 · Cited by 3
Role of AMP-activated protein kinase and sirtuins as antiaging proteins
Ramu, M., Vishal, S. S., & Gogia, N. (2022) · Elsevier eBooks · doi:10.1016/b978-0-323-90235-9.00015-x · Cited by 3
Preparation and physicochemical properties of Nicotinamide@AlOOH biocompatible composite based on sol-gel materials
Vinogradov, V. V., Komova, Y. M., Vinogradov, V. V., & Vinogradov, V. V. (2014) · Nanotechnologies in Russia · doi:10.1134/s1995078014010157 · Cited by 3
Efecto de la deficiencia de hierro sobre la expresión de factor de crecimiento de insulina tipo II y su receptor en células neuronales y gliales
González, E., Contreras, I., & Estrada, J. A. (2013) · Neurología · doi:10.1016/j.nrl.2013.10.005 · Cited by 3
Compatible Changes of Lead microRNAs in Circulating Plasma and Brain in Senescence-Accelerated Aging and Alzheimer’s disease Mouse Models
Bhatnagar, S. (2014) · Journal of Aging Science · doi:10.4172/2329-8847.1000125 · Cited by 2
“By this experimental design, the earliest amyloid-like structures discernible by specific antibody detection are reported at 6-7 months [26,33-35].”
Background
CHARACTERISTICS OF BIOLOGICAL AC TIVITY OF PHOSPHOLIPIDS IN EGG YOLK
Siepka, E., Bobak, Ł., & Gładkowski, W. (2015) · Zywnosc-nauka Technologia Jakosc · doi:10.15193/zntj/2015/99/019 · Cited by 3
Pharmacological Nicotinamide: Mechanisms Centered Around SIRT1 Activity
Hwang, E. S. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-813939-4.00029-2 · Cited by 3
Lipoic acid inhibits cognitive impairment induced by multiple cell phones in young male rats: role of Sirt1 and Atg7 pathway
El-Kafoury, B. M. A., Abdel‐Hady, E. A., Bakly, W. M. S. E., Elayat, W. M., Hamam, G. G., Rahman, S. M. M. A. E., & Lasheen, N. N. (2023) · Scientific Reports · doi:10.1038/s41598-023-44134-2 · Cited by 3
“Correspondingly, Nicotinamide, a Sirt1 inhibitor, attenuated cognitive deficits in mice by promoting neuronal survival via the IGF-1pathway 81 , and through phosphorylation of tau 82 .”
Background
Niacin (Vitamin B3) in Neurodegenerative Disorders: A Comprehensive Review of its Effects on Alzheimer's, Parkinson's, and Huntington's Diseases
Khaksar, Z., & Moradi, H. R. (2026) · The Neuroscience Journal of Shefaye Khatam · doi:10.66224/shefa.14.2.67 · Cited by 2
Micronutrients in the Prevention and Improvement of the Standard Therapy for Alzheimer’s Disease
Prasad, K. N. (2019) · CRC Press eBooks · doi:10.1201/9780429243462-9 · Cited by 2
SIRT2 (Sirtuin2) - An Emerging Regulator of Neuronal Degeneration
Koike, T., Suzuki, K., & Kawahat, T. (2012) · InTech eBooks · doi:10.5772/34722 · Cited by 2
“Nicotinamide is also shown to increase the level of acetylated alpha-tubulin, tau stability, and restore memory loss in a transgenic mouse model of Alzheimer's disease (Green et al., 2008).”
Background
The Contribution of the Amyloid Hypothesis to the Understanding of Alzheimer's Disease: A Critical Overview
Morelli, L., Perry, G. L., & Tagliavini, F. (2012) · International Journal of Alzheimer s Disease · doi:10.1155/2012/709613 · Cited by 2
“In addition to NEP, its homologue, neprilysin-2 (NEP2), was also characterised in the brain [100].”
Background
Histone Deacetylase Inhibitors: A Hope for Cancer Patients
Kabel, A. M., & Baali, F. H. (2015) · The Journal of Cancer Research · doi:10.12691/jcrt-3-3-1 · Cited by 2
“It was found that some cognitive deficits were restored in transgenic mice that have a model of Alzheimer's disease by nicotinamide, a competitive HDI of class III sirtuins [16].”
Background
Tau Phosphorylation
Ávila, J., & Hernández, F. (2010) · Advances in neurobiology · doi:10.1007/978-1-4419-6787-9_3 · Cited by 2
Recent Advances in Approved, Withdrawn, Experimental and Investigational Drugs in Clinical Trials for Alzheimer’s disease
Deshpande, R. (2022) · Medicinal & Analytical Chemistry International · doi:10.23880/macij-16000174 · Cited by 1
Histone Deacetylase Inhibitors: A Novel Therapeutic Approach for Cognitive Disorders
Labrie, V. (2011) · Springer eBooks · doi:10.1007/978-3-642-17426-1_12 · Cited by 2
Sirtuin functions in the brain: From physiological to pathological aspects
Shao, J., Zhang, T., Liu, T., Quan, Y., Fan, L., Liu, J., Yang, X. Y., Xie, Q. R., & Xia, W. (2014) · Journal of Shanghai Jiaotong University (Science) · doi:10.1007/s12204-014-1562-y · Cited by 2
Advances in the Treatment of Alzheimer's Disease
Rafii, M. S. (2012) · Wiley eBooks · doi:10.1002/9781119967309.ch10 · Cited by 2
Molecular physiological studies on health effects of dietary nicotinamide riboside, a vitamin B3
Shi, W. (2019) · doi:10.18174/471911 · Cited by 2
Metabolites associated with type 2 diabetes and Alzheimer’s disease trigger differential intracellular signaling responses in mouse primary neurons
Ball, B. K., Kuhn, M. K., Fleeman, R. M., Proctor, E. A., & Brubaker, D. K. (2025) · Brain Research · doi:10.1016/j.brainres.2025.149819 · Cited by 1
Pharmacological nicotinamide: mechanisms centered around the activities of SIRT1 and other sirtuin proteins
Hwang, E. S. (2025) · Elsevier eBooks · doi:10.1016/b978-0-443-18722-3.00011-6 · Cited by 1
In Situ Activatable Hydrogen‐Bonded Organic Framework‐Based Nanozyme as NADH Peroxidase Mimic Restoring Homeostasis for Treatment of Alzheimer's Disease
Zhang, H., Ya, J., Liao, X., Du, X., Zhao, C., Ren, J., & Qu, X. (2025) · Small · doi:10.1002/smll.202509547 · Cited by 1
An integrative approach to detecting potential blood-based biomarkers of cognitive frailty
Furutani, M., Suganuma, M., Hosoyama, T., Mitsumori, R., Takemura, M., Matsui, Y., Nakano, Y., Niida, S., Ozaki, K., Satake, S., et al. (2025) · The journal of nutrition health & aging · doi:10.1016/j.jnha.2025.100726 · Cited by 1
Therapeutic Potential of HDAC Inhibitors in Neurodegenerative Diseases
Singh, A. K., Sudhan, Y. G., Chandana, S. L., Iyaswamy, A., & Durairajan, S. S. K. (2026) · Springer eBooks · doi:10.1007/978-981-95-6099-8_14 · Cited by 2
Age-Related Changes in Cognitive, Emotional, and Motor Behaviour in Male and Female 3xTg-AD Mice: A Longitudinal Study
Stover, K. R. (2015) · DalSpace (Dalhousie University) · Cited by 1
Opening the genome to reduce cocaine-seeking behavior
LaLumiere, R. T. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1222128110 · Cited by 1
6Chapter Micronutrients for the Prevention of Diabetes and Improvement of the Standard Therapy
Prasad, K. N. (2010) · CRC Press eBooks · doi:10.1201/ebk1439821060-11 · Cited by 1
Preparation of Nicotinoyl Amino Acid Derivatives by Fmoc-Solid Phase Synthesis and Preliminary Studies on the DNA-Binding Properties of Nicotinoyl Derivatives
Zhao, D., & Lü, K. (2016) · Heterocycles · doi:10.3987/com-15-13345 · Cited by 1
Epigenetics of Brain Aging
Cacabelos, R., & Teijido, Ó. (2018) · Elsevier eBooks · doi:10.1016/b978-0-12-811353-0.00074-9 · Cited by 1
Histone Deacetylase Inhibitors As Potential Therapeutic Agents For Various Disorders
Thapa, K., Kumar, S., Sharma, A., Arora, S., Grewal, A. K., & Singh, T. G. (2017) · Journal of Pharmaceutical Technology Research and Management · doi:10.15415/jptrm.2017.52014 · Cited by 1
“Bioorganic & medicinal chemistry letters, 14(21), 5343–5346.”
Antiaging Strategies Based on Sirtuin Activation
Garg, G., & Singh, S. (2023) · Springer eBooks · doi:10.1007/978-981-19-7443-4_14 · Cited by 1
Epigenetic Therapy for Alzheimer’s Disease
Mehak, S. F., Sahu, V., Shivakumar, A. B., Gangadharan, G., & Kabekkodu, S. P. (2023) · Springer eBooks · doi:10.1007/978-981-99-2657-2_10 · Cited by 1
Epigenetics of Alzheimer’s Disease: Past, Present and Future
Adiga, D., Eswaran, S., Sriharikrishnaa, S., Khan, N. G., Kabekkodu, S. P., & Kumar, D. (2023) · BENTHAM SCIENCE PUBLISHERS eBooks · doi:10.2174/9789815136142123010005 · Cited by 1
The Histone Code and Disease
Simonet, N. G., Rasti, G., & Vaquero, A. (2015) · Elsevier eBooks · doi:10.1016/b978-0-12-801899-6.00021-8 · Cited by 3
Micronutrients for the Prevention and Improvement of the Standard Therapy for Parkinson’s Disease
Prasad, K. N. (2019) · CRC Press eBooks · doi:10.1201/9780429243462-10 · Cited by 1
Molecular, Cellular, and Behavioural Effects Produced by Perinatal Asphyxia: Protection by Poly (ADP-Ribose) Polymerase 1 (PARP-1) Inhibition
Neira-Peña, T., Espina-Marchant, P., Rojas-Mancilla, E., Esmar, D., Kraus, C., Muñoz, V., Perez, R. S., Rivera, B., Bustamante, D., Valdés, J. L., et al. (2022) · Springer eBooks · doi:10.1007/978-3-031-15080-7_115 · Cited by 1
The Contribution of Transgenic Models to the Understanding of Alzheimer's Disease Progression and Therapeutic Development
Chabrier, M. A., Neely, K. M., Castello, N. A., & LaFerla, F. M. (2011) · Royal Society of Chemistry eBooks · doi:10.1039/bk9781849731843-00001 · Cited by 1
Self-citation
Genomic effects of food bioactives in neuroprotection
Virmani, A., Ali, S. F., Pinto, L., Zerelli, S., & BINIENDA, Z. K. (2017) · Wiley eBooks · doi:10.1002/9781119101277.ch8 · Cited by 1
Abstracts for the Second International Meeting of the Milan Center for Neuroscience (Neuromi): Prediction and Prevention of Dementia: New Hope (Milan, July 6–8, 2016)
Agosta, F. (2016) · Journal of Alzheimer s Disease · doi:10.3233/jad-169002 · Cited by 1
Brain sterol metabolism : modulating Alzheimer’s disease
Vanmierlo, T. (2010) · Research Publications (Maastricht University) · doi:10.26481/dis.20100930tv
Pharmacodynamic Mechanisms of Tolfenamic Acid Induced SP1 Degradation Relative to Alzheimer's Disease Pathology
Adwan, L. I. (2013) · Digital Commons - URI (University of Rhode Island) · doi:10.23860/diss-adwan-lina-2013
Queen Honeybee and Me: Forever Young? Conserved Pathways for Longevity
Knäblein, J., & Huber, R. (2013) · Wiley eBooks · doi:10.1002/9783527669417.ch26
Impact of iron-deficiency upon behaviour and protein expression in the male mouse with implications for Restless Legs Syndrome
Dowling, P. (2009) · doi:10.53846/goediss-1362
Estudio de las principales vías responsables del efecto terapéutico del sildenafilo sobre el deterioro cognitivo del ratón de senescencia acelerada SAMP8
Orejana, L. (2014) · Deposito Adademico Digital Universidad De Navarra (University of Navarra)
AReversibleEarlyOxidizedRedoxStateThatPrecedes MacromolecularROSDamageinAgingNontransgenicand 3xTg-ADMouseNeurons
Brewer, G. J. (2012)
Design, synthesis and biological evaluation of novel tricyclics as dual cholinesterase (ChE) and amyloid aggregation inhibitors with antioxidant properties
Tin, G. (2014) · UWSpace (University of Waterloo)
Evaluation of inhibitors of histone deacetylases as potential neurotrophic agents
Shukla, S., Muhammad, I., Walker, L., & Tekwani, B. (2014) · Planta Medica · doi:10.1055/s-0034-1382607
Evolution, Sources, and Functions of Antioxidant Systems
Prasad, K. N. (2014) · CRC Press eBooks · doi:10.1201/b17497-4
AQUEOUS CHEMISTRY OF SOME BIO-METAL (II) COMPLEXES WITH NICOTINIC ACID AND ADENINE
Sanjay, S. (2016) · Innovare Academic Sciences Pvt. Ltd. - Innovare Journal of Sciences
Impact of a multi-nutrient diet on cognition, brain metabolism, hemodynamics, and plasticity in apoE4 carrier and apoE knockout mice Diane JansenValerio ZerbiCarola I. F. JanssenDaan van Rooij • Bastian ZinnhardtPieter J. DederenAlan J. WrightLaus M. Broersen • Dieter LutjohannArend HeerschapAmanda J. Kiliaan
Jansen, D., Zerbi, V., Janssen, C. I. F., van Rooij, D., Dederen, P. J. W. C., Heerschap, A., & Broersen, L. M. (2013)
Heterochromatin effects in Friedreich's ataxia and sexual dimorphism
Yandım, C. (2012) · Spiral (Imperial College London) · doi:10.25560/9644
Syntheses and Preliminary Study on the DNA-Binding Property of Nicotinoyl Aspartic Acid Dipeptide and Tetrapeptide
Zhao, D. (2017) · Indian Journal of Pharmaceutical Sciences · doi:10.4172/pharmaceutical-sciences.1000212
“Indian J Pharm Sci 2017;79(1):154-158 Nicotinic acid (NA) and niacinamide are important components of the co-factors, nicotinamide adenine dinucleotide (NAD) and nicotinamide adenine dinucleotide phosphate (NADP), which widely participate in the lipid metabolism, oxidation and anaerobic decomposition of sugars in the…”
Background
Potential Treatments for Alzheimer’s Disease
Farooqui, A. A. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-809937-7.00008-2 · Cited by 1
Nicotinamide as a treatment option of Age-Related Macular Degeneration
Lin, Y., Zipfel, P. F., & Skerka, C. (2017) · Journal of Stem Cell Therapy and Transplantation · doi:10.29328/journal.jsctt.1001006
“Treatment of mice restored cognitive decline related to AD pathology indicate a readily available therapeutic for the treatment [5].”
Background
Discovering Biomarkers of Alzheimer's Disease by Statistical Learning Approaches
Long, J. (2019) · PEARL (University of Plymouth) · doi:10.24382/645
Endogenous Metabolism in Endothelial and Immune Cells Is the Main Source of Tissue Levels of the Vitamin B 3 NicotinamidePreprint
Zeidler, J. D., Chini, C. C. S., Kanamori, K. S., Kashyap, S., Espíndola‐Netto, J. M., Thompson, K. D., Warner, G. M., Cabral, F. S., Peclat, T., Gomez, L. S., et al. (2022) · SSRN Electronic Journal · doi:10.2139/ssrn.4054845
Evolution, Sources, and Functions of Antioxidant Systems
(2014) · CRC Press eBooks · doi:10.1201/b17497-2
Food for thought
Wood, H. B. (2009) · Nature Clinical Practice Neurology · doi:10.1038/ncpneuro0989
Epigenetic modulations induced by natural products
Pavan, A. R., Bonjorno, A. F., Chiba, D. E., Lopes, J. R., Fernandes, L. D. R., & dos Santos, J. L. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-23763-8.00009-9
Metabolism and Receptor Mechanisms of Niacin Action
Boronovskiy, S. E., Сергеевна, К. В., & Nartsissov, Y. R. (2023) · Tsitologiya · doi:10.31857/s0041377123060032
A Percutaneous Delivery System for a Nicotinamide Transdermal Therapeutic System
Kuznetsova, E. G., Ryzhikova, V. A., Salomatina, L. A., Kuryleva, O. M., & Sevastianov, V. I. (2024) · Inorganic Materials Applied Research · doi:10.1134/s2075113324020291
“Owing to the ability to maintain mitochondrial homeostasis, nicotinamide provides the prevention of neuron death and mental impairment [14, 15].”
Decoding HDACs and its inhibitors-artificial intelligence assisted smart software based super computational modelling technology in targeting cancer and neurological disorders of the brain
Rizwan, A., Aqeel, A., & Farooqi, H. (2025) · Network Modeling Analysis in Health Informatics and Bioinformatics · doi:10.1007/s13721-025-00589-z · Cited by 1
Epigenetic insight of Alzheimer’s disease and diabetes
Moorthi, P. V., Basavaraju, P., Nagendran, A. N., & Mariappan, V. (2025) · Elsevier eBooks · doi:10.1016/b978-0-443-40559-4.00001-5
Additional file 2 of Metabolic phenotyping reveals a reduction in the bioavailability of serotonin and kynurenine pathway metabolites in both the urine and serum of individuals living with Alzheimer’s disease
Whiley, L., Chappell, K. E., D’Hondt, E., Lewis, M. R., Jiménez, B., Snowden, S. G., Soininen, H., Kłoszewska, I., Mecocci, P., Tsolaki, M. C., et al. (2021) · Figshare · doi:10.6084/m9.figshare.13550661
Rôle central des glucocorticoïdes et de leurs récepteurs dans l’étiologie de la Maladie d’Alzheimer
Canet, G. (2020) · theses.fr (ABES) · doi:10.70675/c46cedbczd8bbz4a8eza301z82de5785048c
Synthèses d’inhibiteurs de HDAC et leurs tests biologiques (Cytotoxicité, HDAC inhibition)
Ozdarska, K. (2020) · theses.fr (ABES) · doi:10.70675/9f872011z7544z4b35z8e5ezcf4812094c2e
From DNA repair to neurodegeneration: PARP1 mechanisms and inhibitor strategies in Alzheimer’s disease
Banjare, P., & Patel, R. (2026) · DNA repair · doi:10.1016/j.dnarep.2026.103940
Epigenetic modulators as therapeutics for neurodegenerative disorders/Alzheimer’s disease
Halder, D., Prajapati, D., Banerjee, T., Biswas, S., & Ghosh, B. (2026) · Methods in enzymology on CD-ROM/Methods in enzymology · doi:10.1016/bs.mie.2026.06.010
Chemical probes for Alzheimer’s disease targets
Aiken, S., Zarganes‐Tzitzikas, T., & Brennan, P. E. (2026) · Essays in Biochemistry · doi:10.1042/ebc20260014
Gut microbiota as a modulator of HDAC: insights into Alzheimer’s disease treatment
Verma, E., Mishra, S., Chellammal, H. S. J., Khandige, P. S., & Gasmi, A. (2026) · Pharmacological Reports · doi:10.1007/s43440-026-00897-9 · Cited by 1

Authors: Green, K. N., Steffan, J. S., Martinez-Coria, H., Sun, X., Schreiber, S. S., Thompson, L. M., & LaFerla, F. M.
Affiliations: University of California, Irvine (US)
Corresponding author: LaFerla, Frank M.
ORCID: Green, Kim N.
Steffan, Joan S.
Thompson, Leslie Michels
LaFerla, Frank M.
Venue: The Journal of Neuroscience
Publisher: Society for Neuroscience
Published: 2008-11-05
Volume: 28
Issue: 45
Pages: 11500-11510
ISSN: 0270-6474 (ISSN-L)
1529-2401
DOI: 10.1523/jneurosci.3203-08.2008
PMC: PMC2617713
OpenAlex: W2089740883
Cited by: 404
References: 59
Citations by year: 2026: 9 · 2025: 20 · 2024: 25 · 2023: 24 · 2022: 18 · 2021: 23 · 2020: 23 · 2019: 21 · 2018: 21 · 2017: 28 · 2016: 18 · 2015: 18 · 2014: 29 · 2013: 27 · 2012: 28
FWCI: 16.52
Type: journal article
Language: en
Open access: hybrid
doi.org
Licence: cc-by-nc-sa
creativecommons.org/licenses/by-nc-sa/4.0/ (vor, 181 d)
Locations: Journal of Neuroscience (publishedVersion, cc-by-nc-sa)
PubMed Central (publishedVersion)
PubMed (publishedVersion)
Europe PMC (PubMed Central) (acceptedVersion)
Funders: Alzheimer's Drug Discovery Foundation
National Institutes of Health
National Institute on Aging (AG0212982, R01AG021982)
National Institute of Neurological Disorders and Stroke (R01NS052789, NS52789)
Topics: Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
Keywords: nicotinamide, Alzheimer's disease, sirtuins, SIRT1, SIRT2, tau phosphorylation, acetylated alpha-tubulin, microtubule stability, histone deacetylase inhibition, 3xTg-AD mice, cognitive impairment, tau clearance, tauopathy, memory loss
MeSH terms: Alzheimer Disease, Animals, Behavior, Animal, Butyrates, Cell Line, Transformed, Cognition Disorders, Disease Models, Animal, Enzyme Inhibitors, Humans, Mice, Inbred C57BL, Mice, Transgenic, Microtubule-Associated Proteins, Mutation, Niacinamide, Peptide Fragments, Phosphorylation, Threonine, Time Factors, Transfection, Tubulin, Vitamin B Complex, Amyloid beta-Peptides, Amyloid beta-Protein Precursor, tau Proteins, Maze Learning, Sirtuins, Immunoprecipitation, Mice, Presenilin-1

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Nicotinamide Restores Cognition in Alzheimer's Disease Transgenic Mice via a Mechanism Involving Sirtuin Inhibition and Selective Reduction of Thr231-Phosphotau

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks